Q4 2022 Arcutis Biotherapeutics Inc Earnings Call Transcript
Ladies and gentlemen, thank you for standing by, and welcome to Arcutis Biotherapeutics, Inc. Fourth Quarter 2022 Earnings Conference Call. (Operator Instructions) Please note that today's conference is being recorded.
I will now hand the conference over to your speaker host, Eric McIntyre, Head of Investor Relations. Please go ahead.
Thank you, Olivia. Good afternoon, everyone, and thank you for joining Arcutis' Fourth Quarter and Full Year 2022 Earnings Call. Slides are available on the Investors section of our website.
On today's call, we have Frank Watanabe, President and CEO; Scott Burrows, Chief Financial Officer; Ken Lock, Chief Commercial Officer; and Patrick Burnett, Chief Medical Officer. During this call, I'd remind everyone that we will be making forward-looking statements. These statements are subject to certain risks and uncertainties and our actual results may differ materially. We encourage you to review the information disclosed in our latest SEC filings.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |